Cerus
CERS
#7540
Rank
โ‚ฌ0.34 B
Marketcap
1,78ย โ‚ฌ
Share price
-1.43%
Change (1 day)
4.82%
Change (1 year)

Earnings for Cerus (CERS)

Earnings in 2025 (TTM): -โ‚ฌ6.6 Million

According to Cerus's latest financial reports the company's current earnings are โ‚ฌ0.19 Billion. In 2024 the company made an earning of -โ‚ฌ10.2 Million, an increase over its 2023 earnings that were of -โ‚ฌ24.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ6.6 Million-35.27%
2024 -โ‚ฌ10.2 Million-58.95%
2023 -โ‚ฌ24.83 Million-20.74%
2022 -โ‚ฌ31.32 Million-25.7%
2021 -โ‚ฌ42.16 Million-11.99%
2020 -โ‚ฌ47.9 Million-14%
2019 -โ‚ฌ55.7 Million21.73%
2018 -โ‚ฌ45.75 Million-0.65%
2017 -โ‚ฌ46.05 Million-10.96%
2016 -โ‚ฌ51.72 Million4.24%
2015 -โ‚ฌ49.62 Million50.99%
2014 -โ‚ฌ32.87 Million-10.08%
2013 -โ‚ฌ36.55 Million184.13%
2012 -โ‚ฌ12.87 Million-7.91%
2011 -โ‚ฌ13.97 Million
2009 -โ‚ฌ19.73 Million-24.69%
2008 -โ‚ฌ26.2 Million-25.2%
2007 -โ‚ฌ35.02 Million330.54%
2006 -โ‚ฌ8.14 Million1.49%
2005 -โ‚ฌ8.02 Million-61.02%
2004 -โ‚ฌ20.56 Million
2002 -โ‚ฌ50.86 Million10.02%
2001 -โ‚ฌ46.23 Million34.25%
2000 -โ‚ฌ34.44 Million61.02%
1999 -โ‚ฌ21.39 Million-18.81%
1998 -โ‚ฌ26.34 Million93.08%
1997 -โ‚ฌ13.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Haemonetics
HAE
โ‚ฌ0.20 B-3,453.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ8.15 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
โ‚ฌ2.80 B-45,284.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
โ‚ฌ13.28 M-314.00%๐Ÿ‡บ๐Ÿ‡ธ USA